EGFR and lung cancer: In this sense, Huang et al. showed that lung cancer-derived exosomes containing EGFR (epidermal growth factor receptor) induce tolerogenic dendritic cells (DCs) and regulatory T lymphocytes (Treg) which could suppress the tumor antigen-specific CD8+ T cells to promote tumor growth (Table 1) [32].